SCHEMBL21731007

SCHEMBL21731007

CCOC(=O)c1cc2c([nH]c3ccccc32)c(C(N)=O)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.59
ALDH1A1 P00352 5/20 0.59
MAPT P10636 5/20 0.59
GABRP O00591 5/20 0.59
GABRD O14764 5/20 0.59
GABRA1 P14867 5/20 0.59
GABRB1 P18505 5/20 0.59
GABRG2 P18507 5/20 0.59
GABRB3 P28472 5/20 0.59
GABRA5 P31644 5/20 0.59
GABRA3 P34903 5/20 0.59
GABRA2 P47869 5/20 0.59
GABRB2 P47870 5/20 0.59
GABRA4 P48169 5/20 0.59
GABRE P78334 5/20 0.59
GABRA6 Q16445 5/20 0.59
GABRG1 Q8N1C3 5/20 0.59
GABRG3 Q99928 5/20 0.59
GABRQ Q9UN88 5/20 0.59
SMN1; SMN2 Q16637 4/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10857780 0.89 STAT3 (0.69) KDM4EALDH1A1MAPTGABRPGABRD
SCHEMBL29424976 0.87 MAPT (0.71) KDM4EALDH1A1MAPTGABRPGABRD
SCHEMBL21724980 0.87 MAPT (0.71) KDM4EALDH1A1MAPTGABRPGABRD
SCHEMBL2216825 0.85 MAPT (0.77) KDM4EALDH1A1MAPTGABRPGABRD
SCHEMBL28429347 0.84 STAT3 (0.52) KDM4EALDH1A1MAPTGABRPGABRD
SCHEMBL2217085 0.83 GABRP (0.80) KDM4EALDH1A1MAPTGABRPGABRD
SCHEMBL29424987 0.81 HDAC3 (0.55) KDM4EALDH1A1MAPTGABRPGABRD
SCHEMBL2214523 0.81 GABRP (0.66) KDM4EALDH1A1MAPTGABRPGABRD
SCHEMBL28127417 0.81 MEN1 (0.66) KDM4EALDH1A1MAPTGABRPGABRD
SCHEMBL29424986 0.81 STAT3 (0.62) KDM4EALDH1A1MAPTGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020037116-A1 SMALL MOLECULE PYRIN-DOMAIN TARGETED NLRP3 INFLAMMASOME INHIBITORS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2020-02-20 WO disclosed